|
Product Name
|
Tesamorelin |
|
CAS
|
218949-48-5
|
|
Appearance
|
White or white crystalline powder
|
|
Assay
|
Above 99%
|
|
Test
|
HPLC
|
|
Certificate
|
ISO 9001
|
|
Storage Temperature
|
Keep in a cool, dry, dark location in a tightly sealed container or cylinder.
|
Tesamorelin is a synthetic form of growth-hormone-releasing hormone (GHRH) which is used in the treatment of HIV-associated lipodystrophy, approved initially in 2010. It is produced and developed by Theratechnologies, Inc. of Canada. The drug is a synthetic peptide consisting of all 44 amino acids of human GHRH with the addition of a trans-3-hexenoic acid group.
